Evidence map›Paper›PMID 28252135›Full record

ReviewIntegrative biology : quantitative biosciences from nano to macro2017

T cell immunoengineering with advanced biomaterials.

Derfogail Delcassian, Susanne Sattler, Iain E Dunlop

Open access · hybridAbstract readReview
In one paragraph

Review in Integrative biology : quantitative biosciences from nano to macro, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering.Regenerative engineering and translational medicine · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Advanced Materials and Devices for the Regulation and Study of NK Cells.International journal of molecular sciences · 2019
    Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Derfogail DelcassianSchool of Pharmacy, University of Nottingham, NG7 2RD, UK. derfogail.delcassian@nottingham.ac.uk and Koch Institute for Integrative Cancer Research, MIT, Massachusetts, 02139, USA.ORCID 0000-0002-8030-7672
Susanne SattlerImperial College London National Heart and Lung Institute, Du Cane Road, W12 0NN, London, UK.
Iain E DunlopDepartment of Materials, Imperial College London, SW7 2AZ, UK. i.dunlop@imperial.ac.uk.
Imperial College London · GBUniversity of Nottingham · GB

Funding

British Heart Foundation RM/13/1/30157
6 · The paper itself

Abstract

Recent advances in biomaterials design offer the potential to actively control immune cell activation and behaviour. Many human diseases, such as infections, cancer, and autoimmune disorders, are partly mediated by inappropriate or insufficient activation of the immune system. T cells play a central role in the host immune response to these diseases, and so constitute a promising cell type for manipulation. In vivo, T cells are stimulated by antigen presenting cells (APC), therefore to design immunoengineering biomaterials that control T cell behaviour, artificial interfaces that mimic the natural APC-T cell interaction are required. This review draws together research in the design and fabrication of such biomaterial interfaces, and highlights efforts to elucidate key parameters in T cell activation, such as substrate mechanical properties and spatial organization of receptors, illustrating how they can be manipulated by bioengineering approaches to alter T cell function.

Indexed as

AnimalsBiocompatible MaterialsBiomimetic MaterialsCells, CulturedCell SeparationCellular MicroenvironmentHumansImmunogenetic PhenomenaT-LymphocytesBiocompatible Materials

Identifiers

PMID28252135
PMCPMC6034443
OpenAlexW2589164914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.